key: cord-1036925-iecq2cwk
authors: Vuong, Brooke; Dusendang, Jennifer R.; Chang, Sharon B.; Mentakis, Margaret Ann; Shim, Veronica C.; Schmittdiel, Julie; Kuehner, Gillian
title: Outpatient Mastectomy: Factors Influencing Patient Selection and Predictors of Return to Care
date: 2020-10-03
journal: J Am Coll Surg
DOI: 10.1016/j.jamcollsurg.2020.09.015
sha: 84012521c54e78648e9a66b3fda1201da6feacd4
doc_id: 1036925
cord_uid: iecq2cwk

BACKGROUND: Following implementation of the Surgical Home Recovery (SHR) Initiative for mastectomy within a large, integrated health delivery system, most patients are discharged on the day of surgery. We sought to identify predictors of SHR and unplanned return to care (RTC). STUDY DESIGN: Mastectomy cases with and without reconstruction from October 2017 to August 2019 were analyzed. Patient characteristics, operative variables, and multimodal pain management were compared between admitted patients and SHR patients using logistic regression. We identified predictors of RTC in SHR patients, defined as 7-day readmission, reoperation, or emergency department visit. RESULTS: Of 2,648 mastectomies, 1,689 (64%) were outpatient and the average age of patients was 58.5 years. Predictors of SHR included perioperative IV acetaminophen (odds ratio (OR) 1.59, 95% Confidence Interval (CI) 1.28-1.97), perioperative opiates (OR 1.47, 95% CI 1.06-2.02), and operation performed by a high-volume breast surgeon (OR 2.12, 95% CI 1.42-3.18). Bilateral mastectomies (OR 0.70, 95% CI 0.54-0.91), immediate reconstruction (OR 0.52, 95% CI 0.39-0.70), and American Society of Anesthesiologists (ASA) Class 3-4 (OR 0.69, 95% CI 0.54-0.87) decreased the odds of SHR. Of SHR patients, 111/1,689 (7%) patients experienced RTC. Patients with ASA Class 3-4 (OR 2.01, 95% CI 1.29-3.14) and African-American ethnicity (OR 2.30, 95% CI 1.38-4.91) were more likely to RTC; receiving IV Acetaminophen (OR 0.56, 95% CI 0.35-0.88) and filling an opiate prescription (OR 0.51, 95% CI 0.34-0.77) decreased the odds of RTC. CONCLUSION: Surgeon volume and multimodal pain medication increased the odds of SHR. Within the SHR group, ASA Class 3-4 and African American patients increased the likelihood of RTC. This study helps optimize patient selection and perioperative practice for successful SHR.

Critics of same day discharge for mastectomy have denounced it as "drive-through" care. 1 Nonetheless, over time and with more robust support services, the physical and psychological benefits of early discharge after breast surgery have been recognized. 2 Rising mastectomy rates across the United States 3 , coupled with the recent COVID-19 pandemic, have driven health care systems to deliver efficient, effective, and safe care to breast cancer patients.

Currently, one-third of bilateral mastectomies and half of unilateral mastectomies are performed in the outpatient setting. 4 Same day discharge for mastectomy patients mitigates potential harms and costs associated with an inpatient admission, conserves valuable hospital resources, and affords patients postoperative recovery in the comfort of their own homes, without any increase in complication rates. Despite multiple retrospective series concluding that outpatient mastectomy is safe 5, 6, 7, 8 , adoption of this practice varies nationwide. 4, 9, 10 We have previously published our organization's experience with the implementation of the Surgical Home Recovery (SHR) initiative, which enabled the rapid transition from predominantly inpatient to predominantly outpatient mastectomies. 11 The SHR initiative was a coordinated and systematic approach, utilizing a variety of interventions starting with preoperative patient education including drain management, staff and surgeon support for same day discharge, applying Enhanced Recovery After Surgery (ERAS) principles of multimodal pain management, and close post-operative follow-up. Furthermore, we found that complication rates were low for all mastectomy patients and more importantly, the complication rates were the same whether a patient went home the same day as surgery or remained in the hospital overnight.

Since many interventions occurred simultaneously to achieve SHR, it is unclear which interventions were most meaningful to drive these changes. In this paper, we evaluate J o u r n a l P r e -p r o o f independent factors including patient characteristics, operative details, and multimodal pain management, to determine which variables are more strongly associated with SHR. Focusing on SHR patients, we analyzed predictors of unplanned return to care (RTC). Identifying variables that facilitate mastectomy SHR and recognizing factors that place these patients at higher risk for RTC will help surgeons and health care systems provide patients with safe and appropriate recovery after mastectomy.

Kaiser Permanente Northern California (KPNC) provides comprehensive care for more than 4.3 million members across 21 medical centers. In October 2017, KPNC implemented SHR for patients undergoing mastectomy. This was a retrospective review of a prospectively collected database from the electronic health record. This study evaluated all members undergoing unilateral or bilateral mastectomy, including immediate tissue-expander or implant-based reconstruction, between October 2017 and August 2019. The main study outcome was SHR which was defined as the patient being discharged from the hospital on the same calendar day as mastectomy. Among patients who underwent SHR, we assessed RTC. This was defined as any unplanned reoperation, readmission, or emergency department visit for any reason within seven days of mastectomy. The reason for RTC was determined by manual chart review by the surgical authors (BV, GK, SC).

Patients with microvascular free flap reconstruction or other non-breast procedures on the same day as mastectomy were excluded. Patients who were male or undergoing surgery for gynecomastia or gender reassignment were also excluded. The reason for surgery was J o u r n a l P r e -p r o o f determined from text analysis of procedure names, diagnoses associated with the procedure, and chart review. Covariables included patient-level characteristics (age, race/ethnicity, body mass index, neoadjuvant chemotherapy, American Society of Anesthesiologists (ASA) score), 12 operative factors (procedure laterality, reconstruction, nipple sparing technique, axillary node dissection or sentinel node biopsy, length of operation, estimated blood loss, whether the procedure was performed by a high-volume breast surgeon), and multimodal pain management (delta pain score, non-steroidal anti-inflammatory drugs (NSAIDs), liposomal bupivacaine, gabapentin use, intravenous (IV) lidocaine, IV acetaminophen, ketamine injection, locoregional nerve block, opiates).

Body mass index was the latest measurement on or up to one year prior to date of surgery. Neoadjuvant chemotherapy was defined as any chemotherapy for breast cancer in the year prior to mastectomy. Reconstruction, nipple sparing technique, axillary surgery, and estimated blood loss were determined through text analysis of procedure names and operative reports. Surgeons who performed 50 or more breast cases per year were categorized as highvolume.

Delta pain score was the average difference between patient-reported pain on a 0 to 10 visual scale and patient-reported acceptable level of pain throughout all measurements taken on the day of mastectomy. 13 A lower number indicates that the patient-reported pain was lower than the acceptable level of pain, translating into more favorable pain control. Perioperative medications were defined as being received between four hours prior to surgery through the end of the day of mastectomy. In addition, the second model (RTC) included discharge opioids filled between discharge and RTC or end of follow-up (7 days after mastectomy).

Chi-square analysis and Fisher's exact tests for categorical variables and t-tests for continuous variables were used to compare the clinical and peri-operative patient characteristics of the inpatient versus SHR groups and RTC versus no RTC groups. A p-value <0.05 was considered significant. Two separate multivariable logistic regression analyses were performed to identify predictors of SHR and RTC. SAS software, version 9.4 (SAS Institute) was used to analyze the data. In order to account for clustering of physician practices by medical center, we performed generalized linear mixed models with a binomial distribution and logit link function.

There was minimal clustering by medical center in the model predicting RTC, so clustering was removed from the final model. We adjusted both models for the month of the study in which the mastectomy was performed to account for changing discharge practices over time. 14 

Between October 2017 and August 2019, 3,529 mastectomies were performed. We excluded 284 mastectomies ineligible for home recovery due to autologous flap reconstruction or simultaneous non-breast operation, and 597 mastectomies performed for gynecomastia or gender reassignment, leaving 2,648 mastectomies available for analysis. SHR was carried out for 1,689 (64%) patients [Table 1 ], of which only 111 patients had RTC [ Table 2 ]. The average length of J o u r n a l P r e -p r o o f stay for inpatient mastectomies was 28.0 hours, compared to 3.2 hours for outpatient mastectomies. Over the course of the study period, more patients experienced SHR with no significant increase in the rate of RTC [ Figure 1 ].

Home recovery and inpatients had similar baseline characteristics except that patients with home recovery were more likely to be Asian American (23% SHR vs. 17% inpatient) and less likely to be white (52% SHR vs. 58% inpatient), p<0.01. There was no difference in patients undergoing neoadjuvant chemotherapy (NAC), with 14% of the SHR population receiving NAC. More than half (57%) of the SHR population underwent unilateral mastectomy without reconstruction. There were 517 patients who were discharged after reconstruction; of these, 327 were unilateral and 190 bilateral. Fewer patients undergoing nipple sparing mastectomy were discharged the same day (15% SHR vs. 20% inpatient, p<0.01). Nodal surgery was performed in 80% of the home recovery patients. A vast majority (96%) of the SHR patients had their surgery performed by a high-volume breast surgeon. Opiates (89%), IV acetaminophen (58%), and gabapentin (31%) were the most common peri-operative modalities of pain management among the SHR group. The Delta pain score was lower in the SHR group ( Of the 111 RTC patients, 65 (59%) patients presented to the emergency department and were subsequently discharged, 19 (17%) were readmitted, and 27 (24%) underwent a reoperation [ Table 4 ]. The most common reasons for RTC included wound checks, concern for bleeding, and drain concerns. The overall reoperation rate for hematoma evacuation was 1.6% (27/1,689) for SHR patients. ERAS) translated to 100 hospital bed days that could be reallocated and lead to $2.1 million additional revenue at a large comprehensive cancer center. 15 As a high-volume procedure, SHR for mastectomy is a key target in delivering value-based care.

A primary concern about outpatient mastectomy is safety. Other studies have suggested that same day discharge may compromise the quality of care, and have called for detailed studies examining patient-level quality metrics in outpatient mastectomy. 16 The strength of this study is the inclusion of patients undergoing reconstruction, bilateral operations, neoadjuvant chemotherapy and detailed information about perioperative pain management. The adoption of home recovery did not compromise quality of care with only 1.6% of SHR patients requiring a reoperation. Our reoperation rate is lower than the published 5.4% reoperation rate for mastectomy in a National Surgical Quality Improvement Program (NSQIP) review, further demonstrating that same day discharge for mastectomy can be safely performed. 17 

After analyzing patient-level and operative factors as well as perioperative pain control, only two variables increased the likelihood for RTC. African American patients were more than 2.5 times as likely to RTC (OR 2.6, 95% CI 1.38-4.91). ASA Class 3-4 also doubled the odds of an unplanned RTC (OR 2.01, 95% CI 1.29-3.14). Another study evaluating racial disparities in OM found that after adjustment for multiple confounders, Black patients were less likely to undergo OM (OR 0.86; 95% CI 0.80-0.93) compared with white patients. 18 While race/ethnicity was not a significant predictors of OM in our study, it was found to be significant in regards to unplanned RTC. This has been previously seen in other major elective operations, with Black race associated with an increased likelihood for readmission with OR 1.13 after colectomy and 1.44 after gastric bypass. 19 There is established literature demonstrating that there can be a racial bias in perception of pain. 20 However, in a chart review of the 111 patients who had an unplanned RTC in our cohort, only eight patients presented with "pain" as the chief complaint.

With these few patients, we are unable to establish any meaningful relationship between race/ethnicity and adequate pain control.

Compromised access to immediate reconstruction is another concern about outpatient mastectomies. In the United States, the Women's Health and Cancer Rights Act of 1998 The most significant predictor of SHR is undergoing surgery by a high-volume breast surgeon (OR 2.12, 95% CI 1.42-3.18). High-volume breast surgeons were defined as those performing more than fifty breast operations annually within our integrated health delivery system. This definition has been previously used in a study by Morrow, et al, and correlated with an increased adherence to evidence-based practice. 22 Breast surgeons from all 21 medical centers in our health system meet quarterly to share best practices. We attribute a large part of the successful, rapid implementation of the SHR Initiative to the communication among breast leaders, adoption of new practices, and willingness to disseminate this information within their respective facilities.

Other predictors of successful SHR included multimodal pain management. Multimodal anesthesia is one of the overarching principles of ERAS, which has been shown to decrease length of stay across many surgical subspecialties. 13, 23, 24 Smaller studies have shown that applying ERAS principles to breast surgery patients enabled same day discharge without any effect on complication rates. 25 10 IV acetaminophen and receipt of perioperative opiates were associated with 59% and 47% increased odds of outpatient mastectomy respectively. IV acetaminophen also significantly reduced the likelihood of having an unplanned RTC (OR 0.56, 95% CI 0.35-0.88). Unexpectedly, we found that NSAIDs and gabapentin decreased the likelihood of home recovery. One explanation is that the standard acetaminophen and opiates were not sufficient and therefore, the need to add NSAIDs and gabapentin is a surrogate for overall inadequate pain control necessitating inpatient admission. The overall low utilization of NSAIDs, seen in 13% of the outpatient mastectomies, is likely due to the concern for increased risk of bleeding and may reflect the difficulty of the operation.

There were limitations regarding pain management data. Only aggregate data regarding anesthesia placed locoregional blocks were included, such as pectoralis nerve plane (PECS I and PECS II), paravertebral, and erector spinae locations. Any intraoperative surgeon-performed block was not captured. We also did not differentiate between the type of local anesthetic used such as liposomal bupivacaine versus standard bupivacaine for local anesthesia or locoregional nerve block. Furthermore, opioid use post-operatively indicated that a prescription was filled, but the exact morphine equivalent that was taken by the patient is unknown in this study. For this reason, to obtain a global assessment of patients' perioperative pain control, we utilized a delta pain score. Patients undergoing SHR had a lower delta pain score, translating into better pain control (-1.8 SHR vs. -0.9 inpatient, p>0.01). The delta pain score was not a significant predictor of same day discharge nor RTC.

Another limitation of this study is the lack of patient reported outcomes. However, multiple prior studies have shown that there is increased patient satisfaction with SHR. 2, 27, 28 Dumestre, et al. compared the following cohorts based on style of recovery: traditional (n=29), transition (n=11), and ERAS (n=29); ERAS patients had less severe pain (p=0.02) and nausea (p=0.01), and better enjoyed their food (p=0.0002) and felt more rested (p=0.02). 29 

Canadian study by Quan, et al. examined patient reported outcomes after adoption of outpatient mastectomy in the Alberta province. They found that 90% of participants felt "excellent or good" with plan to go home, 90% felt "excellent or good" with to take care of themselves once home, and 87% felt "excellent or good" with how to take care of their drain. 30 SHR permits patients to recuperate in a familiar environment leading to better physical and psychological recovery that emphasizes patient comfort, control, and independence.

This study was initiated prior to the COVID-19 pandemic; however, the results within are timely and relevant to the current needs of our healthcare system. Our prior study demonstrated that outpatient mastectomy is safe and feasible, with no increase in unplanned returns to care as mastectomy has been transitioned to a predominantly outpatient procedure in a large, integrated health system. This current study provides data guiding surgeons in patient selection for SHR, which aligns with the COVID-19 Pandemic Breast Cancer Consortium priority to decrease length of stay, 31, 32 including showing that patients undergoing immediate reconstruction or bilateral mastectomy can be discharged home the same day without an increased likelihood of returning to care. High volume breast surgeons and multimodal pain therapy increase the odds of same day discharge. ASA Class 3-4 and African-American patients have an increase J o u r n a l P r e -p r o o f likelihood of returning to care, identifying potentially vulnerable populations that may benefit from additional outreach. 

Influence of physician, patient, and health care system characteristics on the use of outpatient mastectomy

Medical and psychosocial effects of early discharge after surgery for breast cancer: randomised trial

Why Are There So Many Mastectomies in the United States?

Bilateral and Unilateral Mastectomies in Hospital Inpatient and Ambulatory Settings, 2005-2013: Statistical Brief #201

Same-Day Major Breast Cancer Surgery is Safe: An Analysis of Short-Term Outcomes Using NSQIP Data

Systematic review of day surgery for breast cancer

Definitive surgery for breast cancer performed on an outpatient basis

Incidence of complications in outpatient mastectomy with immediate reconstruction

Utilization of mastectomy and reconstruction in the outpatient setting

Enhanced recovery after surgery (Eras) protocol enables safe same-day discharge after alloplastic breast reconstruction

Implementation of a Post-mastectomy Home Recovery Program in a Large, Integrated Health Care Delivery System

A review of ASA physical status -historical perspectives and modern developments

Enhanced Recovery After Surgery to Change Process Measures and Reduce Opioid Use After Cesarean Delivery: A Quality Improvement Initiative

Mixed effects approach to the analysis of the stepped wedge cluster randomised trial-Investigating the confounding effect of time through simulation

Enhanced REVENUE After Surgery? A Cost-Standardized Enhanced Recovery Pathway for Mastectomy Decreases Length of Stay

Outpatient Mastectomy: Clinical, Payer, and Geographic Influences

Reoperation for Complications after Lumpectomy and Mastectomy for Breast Cancer from the 2012 National Surgical Quality Improvement Program (ACS-NSQIP)

Racial disparities in the use of outpatient mastectomy

Factors related to readmission after major elective surgery

Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites

Outpatient mastectomy and breast reconstructive surgery

Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer

Enhanced recovery after surgery a review

Rapid Recovery Total Joint Arthroplasty is Safe, Efficient, and Cost-Effective in the Veterans Administration Setting

Outpatient definitive breast cancer surgery

Advantages of outpatient breast surgery

Physical, psychological, and economic advantages of accelerated discharge after surgical treatment for breast cancer

Ambulatory surgery for breast cancer patients

Improved Recovery Experience Achieved for Women Undergoing Implant-Based Breast Reconstruction Using an Enhanced Recovery after Surgery Model

Same-Day Surgery for Mastectomy Patients in Alberta: A Perioperative Care Pathway and Quality Improvement Initiative

COVID-19 Pandemic Breast Cancer Consortium's Considerations for Re-entry

American College of Surgeons Local Resumption of Elective Surgery Guidance

J o u r n a l P r e -p r o o f